Phase II trial evaluating the long-term efficacy and peripheral sensory neuropathy of capecitabine plus oxaliplatin (XELOX) as adjuvant therapy in Japanese patients with operated stage III colon cancerTaishi Hata, Hidetoshi Eguchi, Shu Okamura et al.|Scientific Reports|2024Cited by 0